SG11201606351VA - Beta-substituted beta-amino acids and analogs as chemotherapeutic agents - Google Patents

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

Info

Publication number
SG11201606351VA
SG11201606351VA SG11201606351VA SG11201606351VA SG11201606351VA SG 11201606351V A SG11201606351V A SG 11201606351VA SG 11201606351V A SG11201606351V A SG 11201606351VA SG 11201606351V A SG11201606351V A SG 11201606351VA SG 11201606351V A SG11201606351V A SG 11201606351VA
Authority
SG
Singapore
Prior art keywords
beta
analogs
amino acids
chemotherapeutic agents
substituted
Prior art date
Application number
SG11201606351VA
Inventor
Bernd Jandeleit
Wolf-Nicolas Fischer
Kerry J Koller
Original Assignee
Quadriga Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadriga Biosciences Inc filed Critical Quadriga Biosciences Inc
Publication of SG11201606351VA publication Critical patent/SG11201606351VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/46—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/69—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a carbon skeleton substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/32—Esters thereof
    • C07F9/3258—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3264—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
    • C07F9/4808—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
SG11201606351VA 2014-02-03 2015-02-03 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents SG11201606351VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461935246P 2014-02-03 2014-02-03
PCT/US2015/014303 WO2015117147A1 (en) 2014-02-03 2015-02-03 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

Publications (1)

Publication Number Publication Date
SG11201606351VA true SG11201606351VA (en) 2016-09-29

Family

ID=52589758

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201710436WA SG10201710436WA (en) 2014-02-03 2015-02-03 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
SG11201606351VA SG11201606351VA (en) 2014-02-03 2015-02-03 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201710436WA SG10201710436WA (en) 2014-02-03 2015-02-03 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents

Country Status (16)

Country Link
US (5) US9394237B2 (en)
EP (1) EP3102195B1 (en)
JP (3) JP6200603B2 (en)
KR (1) KR101900584B1 (en)
CN (1) CN106163509B (en)
AU (2) AU2015210638B2 (en)
BR (1) BR112016017997A2 (en)
CA (1) CA2938571C (en)
DK (1) DK3102195T3 (en)
ES (1) ES2896882T3 (en)
IL (1) IL247099A0 (en)
MX (1) MX2016010095A (en)
NZ (1) NZ723940A (en)
SG (2) SG10201710436WA (en)
TW (1) TWI597260B (en)
WO (1) WO2015117147A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016017997A2 (en) * 2014-02-03 2017-08-08 Quadriga Biosciences Inc BETA SUBSTITUTED AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS
US20160346240A1 (en) * 2014-02-03 2016-12-01 Quadriga Biosciences, Inc. Methods of chemotherapy using chemotherapeutic agents based on beta-substituted beta-amino acids and analogs
BR112016017993A2 (en) 2014-02-03 2017-08-08 Quadriga Biosciences Inc BETA- SUBSTITUTED GAMMA AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS
KR20180035894A (en) * 2015-08-03 2018-04-06 콰드리가 바이오사이언시스 인코포레이티드 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
CN109174181B (en) * 2018-08-10 2021-05-25 华东师范大学 Preparation and application of mesoporous polymer loaded with bifunctional ionic liquid
WO2022147743A1 (en) * 2021-01-08 2022-07-14 Quadriga Biosciences, Inc. Pharmaceutical compositions of chemotherapeutic agents based on beta-substituted beta-amino acid derivatives
CA3214042A1 (en) 2021-04-05 2022-10-13 Halia Therapeutics, Inc. Nek7 inhibitors

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235594A (en) 1962-04-02 1966-02-15 Frosst & Co Charles E N-acyl-alpha-amino acid amides
US3299104A (en) 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
NL7707161A (en) 1976-07-12 1978-01-16 Merck & Co Inc PROCESS FOR PREPARING 2- (THIAZOLYL OR THIAZOLINYL) THIOPHENYLALKANIC AND ALKANIC ACIDS.
US4339443A (en) 1978-09-22 1982-07-13 Fbc Limited Compounds and compositions
US5516931A (en) 1982-02-01 1996-05-14 Northeastern University Release tag compounds producing ketone signal groups
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
FR2688499B1 (en) * 1992-03-10 1994-05-06 Rhone Poulenc Rorer Sa PROCESS FOR THE PREPARATION OF BETA-PHENYLISOSERINE AND ITS ANALOGS.
US5602278A (en) 1994-10-20 1997-02-11 Kirkpatrick; Lynn N-oxides and derivatives of chlorambucil for treating hypoxic tumor cells
PT797575E (en) 1994-12-13 2004-02-27 Hoffmann La Roche IMITAZOLE DERIVATIVES USED AS PROTEIN KINASE INHIBITORS IN PARTICULAR OF EGF-R TYROSINE KINASE
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP3163391B2 (en) * 1995-03-07 2001-05-08 味の素株式会社 Stilbene derivatives and anticancer agents containing the same
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6306909B1 (en) * 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
CN1131855C (en) 1997-12-16 2003-12-24 沃尼尔·朗伯公司 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0103857D0 (en) 2001-02-16 2001-04-04 Avecia Ltd Preparation of chloromandelic acid
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20030232820A1 (en) 2001-08-29 2003-12-18 Saul Wolfe Method for synthesizing oxazinones
US20040087556A1 (en) 2002-11-06 2004-05-06 Lynn Kirkpatrick N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
JP2004175692A (en) 2002-11-25 2004-06-24 Fuso Pharmaceutical Industries Ltd Antitumor agent
KR20050085636A (en) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
PT1660440E (en) 2003-08-20 2012-05-15 Xenoport Inc Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
JPWO2005044780A1 (en) * 2003-11-10 2007-05-17 杏林製薬株式会社 Aminocarboxylic acid derivatives and their addition salts and S1P receptor modulators
WO2005066122A2 (en) 2003-12-30 2005-07-21 Xenoport, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
AU2005244104B2 (en) 2004-05-08 2012-03-15 Novartis International Pharmaceutical Ltd. 4,5-disubstituted-2-aryl pyrimidines
US20060223866A1 (en) * 2004-08-13 2006-10-05 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
AU2005289887A1 (en) 2004-09-24 2006-04-06 Janssen Pharmaceutica, N.V. Sulfonamide compounds
CA2609900A1 (en) 2005-05-12 2006-11-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acti Ng For And On Behalf Of Arizona State University Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth
JP2008540568A (en) * 2005-05-12 2008-11-20 アテヌオン・リミテッド・ライアビリティ・カンパニー Treatment of inflammatory bowel disease with anti-angiogenic compounds
EP1940843A4 (en) 2005-08-11 2010-09-15 Ariad Pharma Inc Unsaturated heterocyclic derivatives
US20100144681A1 (en) 2005-08-11 2010-06-10 Klaus Fuchs Compounds for the treatment of alzheimer's disease
TWI328730B (en) 2006-06-16 2010-08-11 Ablerex Electronics Co Ltd Maximum power point tracking method and tracker thereof for a solar power system
US8063225B2 (en) 2006-08-14 2011-11-22 Chembridge Corporation Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
US20080045534A1 (en) 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
EP1900729A1 (en) 2006-09-15 2008-03-19 Novartis AG Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
WO2008088690A2 (en) 2007-01-12 2008-07-24 Merck & Co., Inc. A process for preparing diazabicyclo[3.3.1] nonane compounds
GB0705656D0 (en) 2007-03-23 2007-05-02 Addex Pharmaceuticals Sa Novel compounds E1
US20090069419A1 (en) 2007-09-07 2009-03-12 Bernd Jandeleit Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US8410284B2 (en) 2008-10-22 2013-04-02 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
TWI468375B (en) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv Process for the preparation of protected l-alanine derivatives
CN106045893A (en) 2009-01-19 2016-10-26 Abbvie 公司 Apoptosis-inducing agents for treatment of cancer and immune and autoimmune diseases
WO2010120370A2 (en) 2009-04-17 2010-10-21 Xenoport, Inc. Gamma-amino-butyric acid derivatives as gabab receptor ligands
US20100273744A1 (en) 2009-04-24 2010-10-28 Paul Martin Gore Compounds
CN102030683B (en) 2009-09-27 2013-07-31 浙江九洲药业股份有限公司 Sitagliptin intermediate and preparation method and application thereof
RU2627703C2 (en) 2010-07-23 2017-08-10 Конекшис Лайф Сайенсиз Пвт. Лтд. Gpr40 agonists
MX2020004502A (en) 2011-09-02 2022-01-20 Incyte Holdings Corp Heterocyclylamines as pi3k inhibitors.
KR101352635B1 (en) 2011-12-29 2014-01-20 연세대학교 산학협력단 Novel Blocker for Vascular Leakage
EP2746250B1 (en) 2012-12-21 2017-09-27 ABX Advanced Biochemical Compounds GmbH Precursors and process for the production of 18F-labelled amino acids
WO2014109858A1 (en) 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
BR112016017997A2 (en) 2014-02-03 2017-08-08 Quadriga Biosciences Inc BETA SUBSTITUTED AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS
KR20180035894A (en) * 2015-08-03 2018-04-06 콰드리가 바이오사이언시스 인코포레이티드 Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

Also Published As

Publication number Publication date
KR101900584B1 (en) 2018-09-19
IL247099A0 (en) 2016-09-29
US10034847B2 (en) 2018-07-31
US20180078517A1 (en) 2018-03-22
TWI597260B (en) 2017-09-01
CN106163509A (en) 2016-11-23
EP3102195B1 (en) 2021-10-06
AU2017251704A1 (en) 2017-11-09
ES2896882T3 (en) 2022-02-28
JP2019023214A (en) 2019-02-14
EP3102195A1 (en) 2016-12-14
US20150218086A1 (en) 2015-08-06
US20160296484A1 (en) 2016-10-13
WO2015117147A1 (en) 2015-08-06
JP2017505818A (en) 2017-02-23
JP6200603B2 (en) 2017-09-20
JP2017210484A (en) 2017-11-30
AU2015210638A1 (en) 2016-09-22
JP6417003B2 (en) 2018-10-31
US20160289172A1 (en) 2016-10-06
CA2938571A1 (en) 2015-08-06
US9861599B2 (en) 2018-01-09
KR20160114722A (en) 2016-10-05
US20160185710A1 (en) 2016-06-30
DK3102195T3 (en) 2021-12-20
AU2015210638B2 (en) 2017-07-20
BR112016017997A2 (en) 2017-08-08
AU2017251704B2 (en) 2019-03-07
CN106163509B (en) 2019-05-03
CA2938571C (en) 2020-12-22
US10245246B2 (en) 2019-04-02
US9394237B2 (en) 2016-07-19
TW201629006A (en) 2016-08-16
SG10201710436WA (en) 2018-01-30
NZ723940A (en) 2017-12-22
MX2016010095A (en) 2017-02-15

Similar Documents

Publication Publication Date Title
HK1247608A1 (en) Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
ZA201700142B (en) Antisense nucleic acids
HK1251994A1 (en) Nitrile rubber article
IL247663A0 (en) Antisense nucleic acids
SG11201705765VA (en) Novel promoter and uses thereof
ZA201702891B (en) Interferon alpha 2b variants
HK1251256A1 (en) Promoter variants
IL258065B (en) Antisense nucleic acids
HK1248069A1 (en) Desacetoxytubulysin h and analogs thereof
SG10201710436WA (en) Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
HK1252648A1 (en) Amino acid supplementation
ZA201605140B (en) Carbohydrate-enriched recombinant microorganisms
ZA201607059B (en) Omega-3 analogues
GB201506316D0 (en) Novel peptide
GB2524785B8 (en) Injector mount
IL247098A0 (en) Beta-substituted gamma-amino acids and analogs thereof, compositions comprising same and uses thereof
IL252156A0 (en) Aliphatic nitrile with rosy odor
GB201509754D0 (en) Injector
ZA201701203B (en) Conveyors
GB2523854B (en) Circuitry
GB201506360D0 (en) Novel peptide
GB201509216D0 (en) Purseable belt
AU361930S (en) Peg
GB201415235D0 (en) Trans-locating peptide
GB201404910D0 (en) Trans-locating peptide